Summary Slide.png (66.34 kB)

Golimumab as First, Second or at Least Third Biologic Agent in Patients With Rheumatoid Arthritis, Psoriatic Arthritis or Ankylosing Spondylitis -Post Hoc Analysis of a Non-Interventional Study in Germany

Download (66.34 kB)
posted on 09.04.2020 by Klaus Krüger, Gerd Rüdiger Burmester, Siegfried Wassenberg, Matthias. H. Thomas

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.